Market Research Logo

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • KEY DATA FROM SECONDARY SOURCES
    • KEY DATA FROM PRIMARY SOURCES
    • KEY INDUSTRY INSIGHTS
    • ASSUMPTIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • VACCINES MARKET HAS HIGH GROWTH POTENTIAL
    • VACCINES MARKET, BY TYPE
    • VACCINES MARKET, BY REGION
    • VACCINES MARKET, BY DISEASE INDICATION
    • VACCINES MARKET, BY END USER
    • LIFECYCLE ANALYSIS, BY REGION
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • VACCINES MARKET, BY TECHNOLOGY
      • VACCINES MARKET, BY TYPE
      • VACCINES MARKET, BY DISEASE INDICATION
      • VACCINES MARKET, BY END USER
      • VACCINES MARKET, BY REGION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INCREASING PREVALENCE OF DISEASES TO BOOST THE MARKET GROWTH OF VACCINES
      • RESTRAINTS
        • Table HUGE CAPITAL INVESTMENT TO LIMIT THE MARKET GROWTH OF VACCINES
      • OPPORTUNITIES
        • Table INCREASING PREVALENCE OF DISEASES TO BOOST THE MARKET GROWTH OF VACCINES
      • CHALLENGES
        • Table INCREASING PREVALENCE OF DISEASES TO BOOST THE MARKET GROWTH OF VACCINES
      • BURNING ISSUES
  • INDUSTRY INSIGHTS
    • PORTER'S FIVE FORCES ANALYSIS
      • THREAT FROM NEW ENTRANTS
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
      • THREAT OF SUBSTITUTES
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • TECHNOLOGY TRENDS FOR ADJUVANTS
      • DRIVERS
      • RESTRAINS
      • OPPORTUNITIES
      • CHALLENGES
      • TRENDS
    • INVESTMENT ANALYSIS
      • Table NATIONAL INSTITUTES OF HEALTH (NIH) FUNDING FOR VACCINE DEVELOPMENT, 2011-2013 ($MILLION)
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
      • EUROPE
        • Table REGULATORY AUTHORITIES IN EUROPE
      • ASIA
        • Table REGULATORY AUTHORITIES IN ASIA
      • ROW
    • PATENT ANALYSIS
    • KEY PIPELINE PRODUCTS
      • Table KEY PIPELINE VACCINES
    • STRATEGIC BENCHMARKING
  • VACCINES MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
    • SUBUNIT VACCINES
      • Table SUBUNIT VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • LIVE ATTENUATED VACCINES
      • Table LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • CONJUGATE VACCINES
      • Table CONJUGATE VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: CONJUGATE VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: CONJUGATE VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: CONJUGATE VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • INACTIVATED VACCINES
      • Table INACTIVATED VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • RECOMBINANT VECTOR VACCINES
      • Table RECOMBINANT VECTOR VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: RECOMBINANT VECTOR VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: RECOMBINANT VECTOR VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: RECOMBINANT VECTOR VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • TOXOID VACCINES
      • Table TOXOID VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: TOXOID VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: TOXOID VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: TOXOID VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • SYNTHETIC VACCINES
      • Table SYNTHETIC VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: SYNTHETIC VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: SYNTHETIC VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: SYNTHETIC VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • DENDRITIC CELL VACCINES
      • Table DENDRITIC CELL VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: DENDRITIC CELL VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: DENDRITIC CELL VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: DENDRITIC CELL VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
  • VACCINES MARKET, BY TYPE
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
    • PREVENTIVE VACCINES
      • Table PREVENTIVE VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: PREVENTIVE VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: PREVENTIVE VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: PREVENTIVE VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • THERAPEUTIC VACCINES
      • Table THERAPEUTIC VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: THERAPEUTIC VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
  • VACCINES MARKET, BY DISEASE INDICATION
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
    • INFECTIOUS DISEASES
      • Table VACCINES MARKET SIZE FOR INFECTIOUS DISEASES, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2012-2019 ($MILLION)
      • Table INFECTIOUS DISEASES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • PNEUMOCOCCAL
      • INFLUENZA
      • DTP
      • HEPATITIS
      • ROTAVIRUS
      • VARICELLA
      • MENINGOCOCCAL
      • POLIO
      • MMR
      • OTHERS
    • CANCER
      • Table VACCINES MARKET SIZE FOR CANCER, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE FOR CANCER, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE FOR CANCER, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE FOR CANCER, BY COUNTRY, 2012-2019 ($MILLION)
      • Table CANCER VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • CERVICAL CANCER
      • OTHER CANCERS
    • ALLERGIES
      • Table VACCINES MARKET SIZE FOR ALLERGIES, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE FOR ALLERGIES, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE FOR ALLERGIES, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE FOR ALLERGIES, BY COUNTRY, 2012-2019 ($MILLION)
  • VACCINES MARKET, BY END USER
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
    • PEDIATRICS
      • Table VACCINES MARKET SIZE FOR PEDIATRICS, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE FOR PEDIATRICS, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE FOR PEDIATRICS, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE FOR PEDIATRICS, BY COUNTRY, 2012-2019 ($MILLION)
    • ADULTS
      • Table VACCINES MARKET SIZE FOR ADULTS, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE FOR ADULTS, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE FOR ADULTS, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE FOR ADULTS, BY COUNTRY, 2012-2019 ($MILLION)
  • GLOBAL VACCINES MARKET, BY REGION
    • INTRODUCTION
      • Table VACCINES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • U.S.
        • Table U.S.: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table U.S.: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table U.S.: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table U.S.: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • CANADA
        • Table CANADA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table CANADA: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table CANADA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table CANADA: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
    • EUROPE
      • Table EUROPE: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
      • Table EUROPE: VACCINES MARKET SIZE, BY END USERS, 2012-2019 ($MILLION)
      • GERMANY
        • Table GERMANY: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table GERMANY: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table GERMANY: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table GERMANY: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • FRANCE
        • Table FRANCE: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table FRANCE: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table FRANCE: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table FRANCE: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • U.K.
        • Table U.K.: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table U.K.: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table U.K.: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table U.K.: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • ITALY
        • Table ITALY: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table ITALY: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table ITALY: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table ITALY: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • SPAIN
        • Table SPAIN: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table SPAIN: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table SPAIN: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table SPAIN: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table ROE: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table ROE: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table ROE: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
    • ASIA
      • Table ASIA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
      • Table ASIA: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • JAPAN
        • Table JAPAN: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table JAPAN: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table JAPAN: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table JAPAN: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • CHINA
        • Table CHINA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table CHINA: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table CHINA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table CHINA: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • INDIA
        • Table INDIA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table INDIA: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table INDIA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table INDIA: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • REST OF ASIA (ROA)
        • Table ROA: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table ROA: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
        • Table ROA: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
        • Table ROA: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: VACCINES MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ROW: VACCINES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION)
      • Table ROW: VACCINES MARKET SIZE, BY DISEASE INDICATION, 2012-2019 ($MILLION)
      • Table ROW: VACCINES MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS
        • Table RECENT AGREEMENTS AND COLLABORATIONS
      • REGULATORY APPROVALS
        • Table RECENT REGULATORY APPROVALS
      • ACQUISITIONS
        • Table RECENT ACQUISITIONS
      • OTHER DEVELOPMENTS
        • Table RECENT OTHER DEVELOPMENTS
  • COMPANY PROFILES
    • INTRODUCTION
    • GLAXOSMITHKLINE, PLC.
      • BUSINESS OVERVIEW
        • Table EXCHANGE RATES (UTILIZED FOR CONVERSION OF GBP TO USD)
      • PRODUCT PORTFOLIO
      • KEY STRATEGIES
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK & CO., INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SANOFI PASTEUR
      • BUSINESS OVERVIEW
        • Table EXCHANGE RATES (UTILIZED FOR CONVERSION OF EURO TO USD)
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • PFIZER, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVARTIS AG
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BAVARIAN NORDIC
      • BUSINESS OVERVIEW
        • Table EXCHANGE RATES (UTILIZED FOR THE CONVERSION OF DKK TO USD)
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • CSL LIMITED
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • EMERGENT BIOSOLUTIONS, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • JOHNSON & JOHNSON
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • MEDIMMUNE, LLC. (A SUBSIDIARY OF ASTRAZENECA)
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
  • APPENDIX
    • RECENT DEVELOPMENTS
      • GLAXOSMITHKLINE, PLC.
      • SANOFI PASTEUR
      • NOVARTIS AG
      • EMERGENT BIOSOLUTIONS INC.
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • AVAILABLE CUSTOMIZATIONS
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • RELATED REPORTS

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019

The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.

Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries. The emerging markets of the Asian region have opened an array of opportunities for the vaccines market. However, low accessibility to vaccines in remote areas and stringent regulatory procedures are expected to restrain the growth of this market.

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by the industry players over the last three years. In addition, the company profiles comprise the basic views on the key players in the vaccines market and the product portfolios, developments, and strategies adopted by the market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of the future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on product portfolios of the top players in the vaccines market. The report analyzes the vaccines market by type, technology, disease indication, end users, and geography

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the vaccines market

Competitive Assessment: In-depth assessment of the market strategies, geographical and business segments, and product portfolios of the leading players in the vaccines market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various vaccines across geographies

Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the vaccines market


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;